Study Group: Clinical Neurophysiologists (US)(?)
Council Members in this Study Group: 90
Request a survey with this Study Group
Leading Experts in this Study Group
 |
What is a GLG Leader? |
Daniel Wynn, MDDirector, Clinical Research
Consultants In Neurology Ltd.
Daniel Wynn, MD, FACN, FAASM, is a Director of Clinical Research at Consultants in Neurology in Chicago, Illinois. He has expertise in a wide variety of neurological illnesses and has served as a principal investigator in over 100 clinical trials in multiple sclerosis, Alzheimer's disease, stroke, chronic...
Neurologist
Medford Neurological Clinic, Inc.
Walter Carlini, MD, PhD, is a General Neurologist at the Medford Neurological Clinic, Oregon. His clinical interests include stroke, epilepsy, migraine, dementia, movement disorders, and multiple sclerosis. Dr. Carlini has expertise in clinical neurophysiology and in the use of botulinum toxin injections...
Related Study Groups
GLG NewsSMAnalyses by this Study Group's Experts(?)
Extavia, Novartis' brand of interferon beta 1b, has been approved for the treatment of multiple sclerosis by the European Union. With FTY72, Fingolimod, Novartis has the eye on filing NDA by the end of 2009. While essentially identical to Bayer's Betaferon interferon beta 1b,...
The data on ABT-089 in adults has been released with positive results, whereas the adolescent/childhood trial is on-going for this novel compound for ADHD. The key difference is the potential to improve learning, not simply regain attention and lessen hyperactivity.
Surgeons adn patiets need to know that although laser TURP is an attractive and simple technique, patients may still need an alpha blocker to easily initiate voiding afterwards. Further, later catheterization may be difficult due to pocket formation and thus blind-ending the catheter passage rather...
Copaxone has become the leading treatment for relapsing remitting MS in the US. The results of the PRECISE trial will likely add to TEVA's sales momentum and boost sales further.
IVIg (intraveonus immunoglobulin) reduces disability and reduces risk of relapse in patients with CIDP (chronic inflammatory demyelinating polyradiculoneuropathy).
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Office Based Private Practice or Clinic
- Academic Institution*
- Non-Academic Community Hospital or Clinic
Most Common Job Types:
- Physician - Attending Physician
- Physician - Director
- Owner
- Professor
- Physician - Division Head
- Director
- Physician - Department Chair
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms